Evidence map›Paper›PMID 29783767›Full record

ArticleCells2018

Direct Detection of T- and B-Memory Lymphocytes by ImmunoSpot® Assays Reveals HCMV Exposure that Serum Antibodies Fail to Identify.

Fredrik Terlutter, Richard Caspell, Tobias M Nowacki, Alexander Lehmann, Ruliang Li, Ting Zhang, Anna Przybyla, Stefanie Kuerten, Paul V Lehmann

Open access · goldAbstract read
In one paragraph

Article in Cells, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Fredrik TerlutterResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH 44122, USA. fredrik.terlutter@autostereoscopic.de.
Richard CaspellResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH 44122, USA. richard.caspell@immunospot.com.
Tobias M NowackiDepartment of Medicine B, University Hospital of Münster, Albert-Schweitzer-Campus 1, A1, Münster 48149, Germany. t.nowacki@jhwaf.de.
Alexander LehmannResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH 44122, USA. alexander.lehmann@immunospot.com.
Ruliang LiResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH 44122, USA. ruliang.li@immunospot.com.
Ting ZhangResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH 44122, USA. ting.zhang@immunospot.com.
Anna PrzybylaResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH 44122, USA. anna.przybyla@immunospot.com.
Stefanie KuertenInstitute of Anatomy and Cell Biology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen 91054, Germany. stefanie.kuerten@fau.de.ORCID 0000-0001-6119-605X
Paul V LehmannResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH 44122, USA. paul.lehmann@immunospot.com.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is essential to identify donors who have not been infected with human cytomegalovirus (HCMV) in order to avoid transmission of HCMV to recipients of blood transfusions or organ transplants. In the present study, we tested the reliability of seronegativity as an indicator for the lack of HCMV exposure in healthy human blood donors. Eighty-two HCMV seronegative individuals were identified, and their peripheral blood mononuclear cells (PBMC) were tested in ImmunoSpot® assays for the presence of HCMV-specific T- and B-memory lymphocytes. Eighty-two percent (67 of 82) of these HCMV seronegative individuals featured at least one memory cell that was lineage specific for HCMV, with the majority of these subjects possessing CD4+ and CD8+ T cells, as well as B cells, providing three independent lines of evidence for having developed immunity to HCMV. Only 15 of these 82 donors (18%) showed neither T- nor B-cell memory to HCMV, consistent with immunological naïveté to the virus. The data suggest that measurements of serum antibodies frequently fail to reveal HCMV exposure in humans, which may be better identified by direct detection of HCMV-specific memory lymphocytes.

Indexed as

B cellsCD4 T cellsCD8 T cellsELISPOTenzyme-linked ImmunoSpot assayhuman cytomegalovirus (HCMV)serum antibodies

Identifiers

PMID29783767
PMCPMC5981269
OpenAlexW2804693627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.